A phase III randomised trial comparing sequential to standard chemotherapy in advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Sculier, J.
Lafitte, J.
Lecomte, J.
Alexopoulos, C.
Van Cutsem, O.
Giner, V.
Efremidis, A.
Scherpereel, A.
Paesmans, M.
Berghmans, T.
机构：
[1] Inst Jules Bordet, B-1000 Brussels, Belgium
[2] CHU Calmette, Lille, France
[3] CHU Charleroi, Charleroi, Belgium
[4] Evangelismos Gen Hosp, Athens, Greece
[5] Clin Univ St Luc, Namur, Belgium
[6] Hosp Sagunto, Valence, France
[7] Hellen Canc Inst, Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：367S / 367S
页数：1
相关论文
共 50 条
  • [1] Sequential versus standard chemotherapy in advanced non-small cell lung cancer (NSCLC): A phase III randomised trial
    Paesmans, M.
    Berghmans, T.
    Lafitte, J. J.
    Lecomte, J.
    Alexopoulos, C. G.
    Van Cutsem, O.
    Giner, V.
    Efremidis, A.
    Scherpereel, A.
    Sculier, J. P.
    LUNG CANCER, 2006, 52 : S26 - S27
  • [2] Sequential chemotherapy in non-small cell lung cancer (NSCLC)
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4831 - 4832
  • [3] Chemotherapy for advanced non-small cell lung cancer (NSCLC)
    Manegold, C
    LUNG CANCER, 2002, 38 : S47 - S50
  • [4] Sequential (GEP-GT) chemotherapy in advanced non-small cell lung cancer (NSCLC): A phase II study
    Caprioli, A
    Bozzola, G
    Ferrari, VD
    Tassi, GF
    Simoncini, E
    Marini, G
    ANNALS OF ONCOLOGY, 2000, 11 : 5 - 5
  • [5] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC): a randomised phase III trial
    McDonald, F.
    Mak, K. M.
    Teague, J.
    Landau, D.
    Hanna, G.
    Farrelly, L.
    Counsell, N.
    LUNG CANCER, 2020, 139 : S91 - S91
  • [6] A Randomized Phase III Clinical Trial of Anlotinib Hydrochloride in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Han, Baohui
    Li, Kai
    Zhao, Yizhuo
    Wang, Qiming
    Zhang, Li
    Shi, Jianhua
    Wang, Zhehai
    He, Jianxing
    Shi, Yuankai
    Cheng, Yin
    Chen, Weiqiang
    Wang, Xiuwen
    Luo, Yi
    Nan, Kejun
    Jin, Faguang
    Dong, Jian
    Li, Baolan
    Zhou, Jianying
    Chen, Yinlan
    Wang, Donglin
    Zhou, Xin
    Yu, Yan
    Chen, Liming
    Liu, Anwen
    Huang, Jianjin
    Huang, Cheng
    Cao, Bangwei
    Chen, Jun
    Ma, Rui
    Yu, Zhuang
    Ding, Cuimin
    Wang, Hongbing
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S886 - S887
  • [7] Prognostic score for second-line chemotherapy of advanced non-small cell lung cancer (NSCLC): External validation in a phase III trial comparing vinflunine with docetaxel.
    Krzakowski, M. J.
    Di Maio, M.
    Perraud, K.
    Kowalski, D. M.
    Gridelli, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Vinorelbine/gemcitabine in advanced non-small cell lung cancer (NSCLC):: a phase I trial
    Krajnik, G
    Wein, W
    Greil, R
    Marhold, F
    Mohn-Staudner, A
    Kummer, F
    Malayeri, R
    Zöchbauer-Müller, S
    Huber, H
    Pirker, R
    EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1977 - 1980
  • [9] A phase III randomised, double blind, placebo controlled trial of gemcitabine/carboplatin with or without thalidomide in advanced non-small cell lung cancer (NSCLC)
    Lee Siow-Ming
    Woll, Penella J.
    Rudd, Robin M.
    Gower, Nicole H.
    Ottensmeier, Christian H.
    Ali, Kulsam
    Spiro, Stephen G.
    Hackshaw, Allan
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S359 - S359
  • [10] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial
    Landau, D. B.
    Hughes, L.
    Ngai, Y.
    Hanna, G. G.
    Conibear, J.
    Farrelly, L.
    Counsell, N.
    LUNG CANCER, 2017, 103 : S54 - S54
12345